Jolanta Parada-Turska

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. ncbi Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, 20 090 Lublin, Poland
    Inflammation 31:281-5. 2008
  2. ncbi [The musculoskeletal system in diabetic patients]
    Jolanta Parada-Turska
    Katedra i Klinika Reumatologii i Układowych Chorób Tkanki Łacznej, Akademia Medyczna, Lublin
    Postepy Hig Med Dosw (Online) 59:236-44. 2005
  3. ncbi Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, 20 950 Lublin, Poland
    Rheumatol Int 26:422-6. 2006
  4. ncbi Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, 20 950 Lublin, Poland
    Eur J Pharmacol 535:95-7. 2006
  5. ncbi Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, PL 20 090 Lublin, Poland
    Pharmacol Rep 59:233-7. 2007
  6. ncbi Kynurenic acid in human saliva--does it influence oral microflora?
    Damian Kuc
    Department of Clinical and Experimental Pharmacology, Medical University, Jaczewskiego 8, PL 20 090 Lublin, Poland
    Pharmacol Rep 58:393-8. 2006
  7. ncbi Retigabine: the newer potential antiepileptic drug
    Piotr Czuczwar
    Department of Human Anatomy, Medical University, Jaczewskiego 4, PL 20 090 Lublin, Poland
    Pharmacol Rep 62:211-9. 2010
  8. ncbi Allopurinol does not affect the anticonvulsant activity of carbamazepine and valproate in maximal electroshock-induced convulsions in mice
    Jolanta Parada-Turska
    Department of Rheumatology, Medical University, Jaczewskiego 8, PL 20 090 Lublin, Poland
    Pol J Pharmacol 56:67-72. 2004
  9. ncbi Lithium-methomyl induced seizures in rats: a new model of status epilepticus?
    Rafal M Kaminski
    Department of Toxicology, Institute of Agricultural Medicine, Jaczewskiego 2, 20 950 Lublin, Poland
    Toxicol Appl Pharmacol 219:122-7. 2007
  10. ncbi Effect of kynurenic acid on the viability of probiotics in vitro
    Jadwiga Dolecka
    Department of Genetics and Microbiology, Institute of Microbiology and Biotechnology, Maria Curie Skłodowska University, Akademicka 19, PL 20 033 Lublin, Poland
    Pharmacol Rep 63:548-51. 2011

Collaborators

Detail Information

Publications12

  1. ncbi Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, 20 090 Lublin, Poland
    Inflammation 31:281-5. 2008
    ..Parthenolide inhibited proliferation of HIG-82 and human RA-FLS. The proliferation of HSF was inhibited less effectively. The antiproliferative potential of parthenolide was demonstrated...
  2. ncbi [The musculoskeletal system in diabetic patients]
    Jolanta Parada-Turska
    Katedra i Klinika Reumatologii i Układowych Chorób Tkanki Łacznej, Akademia Medyczna, Lublin
    Postepy Hig Med Dosw (Online) 59:236-44. 2005
    ..Moreover, carpal tunnel syndrome, gout, osteoarthritis and their probable association with diabetes mellitus are discussed...
  3. ncbi Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, 20 950 Lublin, Poland
    Rheumatol Int 26:422-6. 2006
    ..In conclusion, the presence of kynurenic acid in synovial fluid was documented in patients with rheumatoid arthritis. Its potential role as an endogenous substance, controlling synoviocyte proliferation can be suggested...
  4. ncbi Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, 20 950 Lublin, Poland
    Eur J Pharmacol 535:95-7. 2006
    ..0043, 0.034, 0.044, 0.096, 0.385 and 1.123, respectively. Thus, the antiproliferative potential of glutamate receptor antagonists is comparable to that of antirheumatic drugs...
  5. ncbi Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells
    Jolanta Parada-Turska
    Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, PL 20 090 Lublin, Poland
    Pharmacol Rep 59:233-7. 2007
    ..3, 6.5, 7.0 and 2.8, respectively. Thus, the antiproliferative potential of parthenolide was confirmed...
  6. ncbi Kynurenic acid in human saliva--does it influence oral microflora?
    Damian Kuc
    Department of Clinical and Experimental Pharmacology, Medical University, Jaczewskiego 8, PL 20 090 Lublin, Poland
    Pharmacol Rep 58:393-8. 2006
    ..The bactericidal effect of KYNA was also presented. We hypothesize that KYNA may contribute to the control of oral microflora...
  7. ncbi Retigabine: the newer potential antiepileptic drug
    Piotr Czuczwar
    Department of Human Anatomy, Medical University, Jaczewskiego 4, PL 20 090 Lublin, Poland
    Pharmacol Rep 62:211-9. 2010
    ..Initial clinical data suggest that retigabine may be also effective in Alzheimer's disease or stroke...
  8. ncbi Allopurinol does not affect the anticonvulsant activity of carbamazepine and valproate in maximal electroshock-induced convulsions in mice
    Jolanta Parada-Turska
    Department of Rheumatology, Medical University, Jaczewskiego 8, PL 20 090 Lublin, Poland
    Pol J Pharmacol 56:67-72. 2004
    ..Thus, our results did not support suggestions that allopurinol can be beneficial as add-on drug in the management of epilepsy at least in patients treated with CBZ or VPA...
  9. ncbi Lithium-methomyl induced seizures in rats: a new model of status epilepticus?
    Rafal M Kaminski
    Department of Toxicology, Institute of Agricultural Medicine, Jaczewskiego 2, 20 950 Lublin, Poland
    Toxicol Appl Pharmacol 219:122-7. 2007
    ..As such, seizures induced by lithium-methomyl administration may be an alternative to lithium-pilocarpine model of status epilepticus, which is associated with high lethality...
  10. ncbi Effect of kynurenic acid on the viability of probiotics in vitro
    Jadwiga Dolecka
    Department of Genetics and Microbiology, Institute of Microbiology and Biotechnology, Maria Curie Skłodowska University, Akademicka 19, PL 20 033 Lublin, Poland
    Pharmacol Rep 63:548-51. 2011
    ..lactis BB-12). Our results suggest a potential role of KYNA in the regulation of bacterial growth in the digestive system...
  11. ncbi Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor
    Katarzyna Wejksza
    Department of Virology and Immunology, Institute of Microbiology and Biotechnology, Maria-Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, Poland
    Naunyn Schmiedebergs Arch Pharmacol 369:300-4. 2004
    ..D,L-Homocysteine and L-homocysteine sulphinic acid lowered KYNA production in BAEC. Further investigations are needed to assess the role and importance of KYNA in vessels and peripheral tissues...
  12. ncbi Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice
    Jarogniew J Luszczki
    Department of Pathophysiology, Medical University, Lublin, Poland
    Neuropsychopharmacology 28:1817-30. 2003
    ..Combinations of TGB with GBP (very promising from a preclinical point of view) should be clinically verified for elaborating the most effective treatment regimen in patients with intractable seizures...